Oddo BHF downgraded Novartis to Neutral from Outperform. The analyst sees limited valuation upside and clinical news flow in the near-term.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVS:
